🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A comparison of the efficacy of APD421 and placebo in the prevention of PON...
Status
Completed
Location
CHU de Hautepierre
Start Date
2013-07
Trial ID
NCT01991821
To assess the effectiveness of Amisulpride to treat Post Operative Nausea a...
Status
Recruiting
Location
Virginia Mason Medical Center
Start Date
2024-09-13
Trial ID
NCT06585540
Treatments Being Tested
A comparison of the efficacy of APD421 and placebo when combined with a sta...
Status
Completed
Location
Helen Keller Hospital
Start Date
2015-02
Trial ID
NCT02337062
Amisulpride is a potent antagonist of dopamine D2 and D3 receptors, both im...
Status
Recruiting
Location
Hospital da Mulher
Start Date
2025-04-10
Trial ID
NCT06887621
Double-blind, randomised, parallel-group, placebo-controlled, adaptive, sea...
Status
Completed
Location
Jackson Memorial Hospital
Start Date
2015-09
Trial ID
NCT02449291
A comparison of the efficacy of APD421 and placebo in the prevention of PON...
Status
Completed
Location
Duke
Start Date
2013-08
Trial ID
NCT01991860
Treatments Being Tested
Double-blind, randomised, parallel-group, placebo-controlled, adaptive, sea...
Status
Completed
Location
Jackson Memorial Hospital
Start Date
2016-03
Trial ID
NCT02646566
A comparison of the efficacy of Amisulpride and placebo in the prevention o...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04-29
Trial ID
NCT05822713
Treatments Being Tested
Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of...
Status
Completed
Location
Helen Keller Hospital
Start Date
2024-01-18
Trial ID
NCT05546359
Treatments Being Tested
Comparison of efficacy of APD403 at preventing delayed sickness in patients...
Status
Completed
Location
Odense University Hospital
Start Date
2013-10
Trial ID
NCT01857232
Treatments Being Tested